Stockreport

Dicerna Announces Closing of $70 Million Convertible Preferred Stock Financing

Dicerna Pharmaceuticals, Inc.  (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) (the “Company”), a leading developer of investigational ribonucleic acid in [Read more]